161 related articles for article (PubMed ID: 28242790)
41. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
42. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
43. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
44. Pattern of metastatic spread in triple-negative breast cancer.
Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
Breast Cancer Res Treat; 2009 May; 115(2):423-8. PubMed ID: 18543098
[TBL] [Abstract][Full Text] [Related]
45. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
46. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
47. Competing causes of death for women with breast cancer and change over time from 1975 to 2003.
Du XL; Fox EE; Lai D
Am J Clin Oncol; 2008 Apr; 31(2):105-16. PubMed ID: 18391593
[TBL] [Abstract][Full Text] [Related]
48. Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
Globus O; Sagie S; Lavine N; Barchana DI; Urban D
PLoS One; 2023; 18(9):e0281561. PubMed ID: 37751439
[TBL] [Abstract][Full Text] [Related]
49. Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
Frasca M; Sabathe C; Delaloge S; Galvin A; Patsouris A; Levy C; Mouret-Reynier MA; Desmoulins I; Vanlemmens L; Bachelot T; Goncalves A; Perotin V; Uwer L; Frenel JS; Ferrero JM; Bouleuc C; Eymard JC; Dieras V; Leheurteur M; Petit T; Dalenc F; Jaffre A; Chevrot M; Courtinard C; Mathoulin-Pelissier S
Eur J Cancer; 2020 Sep; 137():240-249. PubMed ID: 32805641
[TBL] [Abstract][Full Text] [Related]
50. Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting.
Bhoo-Pathy N; Verkooijen HM; Tan EY; Miao H; Taib NA; Brand JS; Dent RA; See MH; Subramaniam S; Chan P; Lee SC; Hartman M; Yip CH
Sci Rep; 2015 Nov; 5():16252. PubMed ID: 26536962
[TBL] [Abstract][Full Text] [Related]
51. De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
Conte B; Soldato D; Razeti MG; Fregatti P; de Azambuja E; Schettini F; Prat A; Del Mastro L; Lambertini M
Clin Breast Cancer; 2022 Jan; 22(1):78-87. PubMed ID: 34750070
[TBL] [Abstract][Full Text] [Related]
52. Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?
Patel JK; Nemoto T; Vezeridis M; Petrelli N; Suh O; Dao TL
Cancer; 1986 Feb; 57(3):567-70. PubMed ID: 2417678
[TBL] [Abstract][Full Text] [Related]
53. Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.
Miao H; Hartman M; Bhoo-Pathy N; Lee SC; Taib NA; Tan EY; Chan P; Moons KG; Wong HS; Goh J; Rahim SM; Yip CH; Verkooijen HM
PLoS One; 2014; 9(4):e93755. PubMed ID: 24695692
[TBL] [Abstract][Full Text] [Related]
54. Elimination of "lead time" bias in assessing the effect of early breast cancer diagnosis.
Jacques PF; Hartz SC; Tuthill RW; Hollingsworth C
Am J Epidemiol; 1981 Jan; 113(1):93-7. PubMed ID: 7457482
[TBL] [Abstract][Full Text] [Related]
55. Cancer of the breast: Its outcome as measured by the rate of dying and causes of death.
Mueller CB; Jeffries W
Ann Surg; 1975 Sep; 182(3):334-41. PubMed ID: 1174299
[TBL] [Abstract][Full Text] [Related]
56. Age-related disparities in older women with breast cancer.
Bagegni NA; Peterson LL
Adv Cancer Res; 2020; 146():23-56. PubMed ID: 32241391
[TBL] [Abstract][Full Text] [Related]
57. Causes of death in breast cancer: a clinicopathologic study.
Hagemeister FB; Buzdar AU; Luna MA; Blumenschein GR
Cancer; 1980 Jul; 46(1):162-7. PubMed ID: 7388758
[TBL] [Abstract][Full Text] [Related]
58. Use of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016.
Ferrario A; Zhang F; Ross-Degnan D; Wharam JF; Twaddle ML; Wagner AK
JCO Oncol Pract; 2022 May; 18(5):e677-e687. PubMed ID: 34986008
[TBL] [Abstract][Full Text] [Related]
59. Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer.
Marie L; Braik D; Abdel-Razeq N; Abu-Fares H; Al-Thunaibat A; Abdel-Razeq H
Cancer Manag Res; 2022; 14():2519-2531. PubMed ID: 36039341
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
